首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗病毒药物在新型冠状病毒肺炎患儿应用中的药学监护
引用本文:王妍,田丹丽,孙燕燕,柏亚林,朱立勤.抗病毒药物在新型冠状病毒肺炎患儿应用中的药学监护[J].中国医院药学杂志,2020,40(6):622-625.
作者姓名:王妍  田丹丽  孙燕燕  柏亚林  朱立勤
作者单位:1. 天津市儿童医院药剂科, 天津 300134;2. 天津市第一中心医院药学部, 天津 300192
摘    要:目的:提高抗新型冠状病毒药物在儿童患者中应用的安全性及合理性。方法:查阅相关文献资料,从药物剂型的选择、儿童应用的年龄限制、剂量、对肝肾功能影响、不良反应、相互作用、使用方法等内容进行全面的分析总结。结果:针对儿童这类特殊人群,临床药师给出了合理的用药建议。结论:用于抗新型冠状病毒的治疗药物在小儿中应加强药学监护,确保小儿用药的安全性、合理性。

关 键 词:新型冠状病毒肺炎  小儿  药学监护
收稿时间:2020-02-12

Pharmaceutical care of antiviral drugs in children with COVID-19
WANG Yan,TIAN Dan-li,SUN Yan-yan,BAI Ya-lin,ZHU Li-qin.Pharmaceutical care of antiviral drugs in children with COVID-19[J].Chinese Journal of Hospital Pharmacy,2020,40(6):622-625.
Authors:WANG Yan  TIAN Dan-li  SUN Yan-yan  BAI Ya-lin  ZHU Li-qin
Institution:1. Department of Pharmacy, Tianjin Children's Hospital, Tianjin 300134, China;2. Department of Pharmacy, Tianjin First Central Hospital, Tianjin 300192, China
Abstract:OBJECTIVE To improve the safety and rationality of anti-novel coronavirus drugs in pediatric patients.METHODS The related literatures were reviewed, and the selection of drug dosage form, age limit of application in children, dosage, effect on liver and kidney function, adverse reactions, interaction and method of application were comprehensively analyzed and summarized.RESULTS For special populations like children, clinical pharmacists offered reasonable medication recommendations.CONCLUSION To ensure the safety and rationality of medication in children, pharmaceutical care should be strengthened in treatment of COVID-19 in children.
Keywords:COVID-19  children  pharmaceutical care  
本文献已被 维普 等数据库收录!
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号